<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-two patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in complete remission induced by either <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> or a combination of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, oncovin and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> were randomized to receive or not to receive prophylactic cerebrospinal irradiation </plain></SENT>
<SENT sid="1" pm="."><plain>Six of 11 irradiated patients relapsed with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system as compared to 4 of 11 controls </plain></SENT>
<SENT sid="2" pm="."><plain>Relapse frequency appeared to be related to stage of disease on admission </plain></SENT>
<SENT sid="3" pm="."><plain>It is concluded that irradiation does not prevent relapse </plain></SENT>
</text></document>